Effect of Cilostazol on Cerebral Vasospasm and Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage: A Randomized, Double-Blind, Placebo-Controlled Trial

Naoya Matsuda, Masato Naraoka, Hiroki Ohkuma, Norihito Shimamura, Katsuhiro Ito, Kenichiro Asano, Seiko Hasegawa, Atsuhito Takemura

Cerebrovascular Diseases · 2016 · 74 citations · 39 references

Abstract

Cilostazol administration is effective in preventing sVS and improving outcomes without severe adverse events. A larger-scale study including more cases was necessary to confirm this efficacy of cilostazol.

References

39